Interleukin-5 Antagonist [EPC]

Interleukin-5 Antagonist [EPC] was reported 688 times

Drugs of the Interleukin-5 Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 PLETHYSMOGRAPHY 25 0.9615
1 TOTAL LUNG CAPACITY INCREASED 187 0.6875
2 SPUTUM CULTURE 25 0.6757
3 HEART SOUNDS 63 0.6562
4 AIRWAY REMODELLING 69 0.5565
5 HEPATIC ENZYME 80 0.5369
6 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 261 0.4990
7 REVERSIBLE AIRWAYS OBSTRUCTION 226 0.4449
8 VITAL CAPACITY DECREASED 184 0.4107
9 TOTAL LUNG CAPACITY ABNORMAL 153 0.3933
10 HYPOCHOLESTEROLAEMIA 138 0.3909
11 PROLONGED EXPIRATION 100 0.3817
12 PULMONARY VASCULITIS 189 0.3513
13 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 692 0.3390
14 EOSINOPHIL COUNT ABNORMAL 232 0.3106
15 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 272 0.2934
16 SPIROMETRY ABNORMAL 173 0.2893
17 EOSINOPHILIC BRONCHITIS 57 0.2850
18 CENTRAL NERVOUS SYSTEM MASS 27 0.2842
19 ANTACID THERAPY 36 0.2769
20 CAPILLARITIS 72 0.2609
21 MITE ALLERGY 164 0.2504
22 WALL MOTION SCORE INDEX ABNORMAL 27 0.2455
23 LUNG DIFFUSION DISORDER 38 0.2420
24 FUNGAL DISEASE CARRIER 24 0.2376
25 FACET JOINT SYNDROME 773 0.2372
26 ACQUIRED FACTOR V DEFICIENCY 26 0.2364
27 COAGULATION FACTOR V LEVEL ABNORMAL 29 0.2358
28 RESPIRATORY GAS EXCHANGE DISORDER 79 0.2129
29 NASAL POLYPECTOMY 33 0.2075
30 CONGENITAL HIATUS HERNIA 47 0.2061
31 OBSTRUCTIVE AIRWAYS DISORDER 2205 0.1980
32 VOCAL CORD DYSFUNCTION 97 0.1968
33 PULMONARY FUNCTION TEST ABNORMAL 299 0.1918
34 MALIGNANT MELANOMA STAGE 0 40 0.1914
35 BRONCHIAL WALL THICKENING 136 0.1892
36 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 3148 0.1852
37 COAGULATION FACTOR DEFICIENCY 29 0.1801
38 PERIPHERAL VENOUS DISEASE 733 0.1793
39 MYCOTIC ALLERGY 152 0.1778
40 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 130 0.1774
41 FULL BLOOD COUNT ABNORMAL 1873 0.1769
42 LARYNGEAL STENOSIS 102 0.1765
43 ATOPY 49 0.1763
44 OVERLAP SYNDROME 123 0.1757
45 NASAL POLYPS 852 0.1729
46 BRONCHIAL SECRETION RETENTION 220 0.1727
47 SLEEP DISORDER THERAPY 34 0.1717
48 ASTHMATIC CRISIS 618 0.1690
49 DUST ALLERGY 164 0.1672
50 FORCED EXPIRATORY VOLUME ABNORMAL 24 0.1655
51 PARATHYROID GLAND ENLARGEMENT 23 0.1608
52 ONYCHOMADESIS 672 0.1600
53 SPUTUM PURULENT 105 0.1596
54 CHRONIC RHINOSINUSITIS WITH NASAL POLYPS 23 0.1554
55 RESPIRATORY SYMPTOM 433 0.1521
56 QUARANTINE 30 0.1463
57 FACTOR V LEIDEN MUTATION 58 0.1461
58 PATIENT ISOLATION 31 0.1442
59 MYCOBACTERIUM TEST POSITIVE 29 0.1408
60 BRONCHIAL OBSTRUCTION 196 0.1395
61 SPUTUM CULTURE POSITIVE 112 0.1379
62 BLOOD IMMUNOGLOBULIN E INCREASED 317 0.1308
63 BLEPHAROSPASM 813 0.1290
64 ANTICOAGULANT THERAPY 36 0.1268
65 LYMPH NODE CALCIFICATION 24 0.1237
66 ASTHMA EXERCISE INDUCED 43 0.1236
67 RHEUMATIC FEVER 546 0.1224
68 NEURITIS 189 0.1223
69 WHEEZING 7232 0.1218
70 EOSINOPHILIC PNEUMONIA CHRONIC 35 0.1178
71 LUNG HYPERINFLATION 101 0.1174
72 SPUTUM DISCOLOURED 1111 0.1170
73 BREAST CANCER STAGE III 756 0.1166
74 ASTHMA 12947 0.1144
75 CONJUNCTIVITIS ALLERGIC 169 0.1140
76 SWOLLEN JOINT COUNT 28 0.1120
77 CHRONIC SINUSITIS 420 0.1118
78 ONYCHOMYCOSIS 490 0.1116
79 HYPEREOSINOPHILIC SYNDROME 60 0.1109
80 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 793 0.1106
81 ANALGESIC THERAPY 35 0.1090
82 FORCED EXPIRATORY VOLUME DECREASED 308 0.1086
83 PEAK EXPIRATORY FLOW RATE DECREASED 47 0.1068
84 VAGINAL FLATULENCE 32 0.1056
85 EOSINOPHIL COUNT INCREASED 866 0.1038
86 DRUG THERAPY 35 0.1032
87 BREATH SOUNDS ABNORMAL 509 0.1031
88 RHINITIS ALLERGIC 457 0.1026
89 LUNG DIFFUSION TEST DECREASED 40 0.1003
90 TOTAL LUNG CAPACITY DECREASED 159 0.0995
91 BACTERIAL DISEASE CARRIER 71 0.0974
92 DUODENAL ULCER PERFORATION 715 0.0961
93 LUPUS VULGARIS 119 0.0944
94 BRONCHIECTASIS 622 0.0922
95 MUSCLE INJURY 753 0.0908
96 FOLLICULITIS 951 0.0906
97 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 4281 0.0890
98 BLOOD COUNT ABNORMAL 1343 0.0885
99 DISLOCATION OF VERTEBRA 202 0.0885
100 RESTRICTIVE PULMONARY DISEASE 103 0.0879
101 RESPIRATORY TRACT INFLAMMATION 40 0.0858
102 CHEST X-RAY ABNORMAL 260 0.0847
103 NSAID EXACERBATED RESPIRATORY DISEASE 32 0.0847
104 CORONAVIRUS TEST POSITIVE 87 0.0845
105 HYPERCHOLESTEROLAEMIA 813 0.0841
106 INSPIRATORY CAPACITY DECREASED 23 0.0830
107 VENOUS PRESSURE JUGULAR INCREASED 30 0.0826
108 SINONASAL OBSTRUCTION 32 0.0796
109 FORCED VITAL CAPACITY DECREASED 51 0.0781
110 BRONCHIAL HYPERREACTIVITY 93 0.0773
111 LIP DRY 702 0.0772
112 FINGER DEFORMITY 369 0.0761
113 NAIL DISORDER 658 0.0751
114 UPPER-AIRWAY COUGH SYNDROME 612 0.0742
115 INFUSION SITE REACTION 221 0.0739
116 HELICOBACTER INFECTION 745 0.0724
117 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 5093 0.0715
118 PRODUCT COMPLAINT 1810 0.0714
119 C-REACTIVE PROTEIN ABNORMAL 456 0.0710
120 SPUTUM ABNORMAL 47 0.0709
121 BURSITIS 847 0.0697
122 EAR PRURITUS 244 0.0695
123 PEMPHIGUS 869 0.0694
124 SPUTUM RETENTION 68 0.0686
125 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 37 0.0660
126 WOUND INFECTION 700 0.0639
127 LUNG OPACITY 168 0.0637
128 EXPOSURE VIA SKIN CONTACT 1615 0.0623
129 RETINITIS 107 0.0619
130 ASPIRIN-EXACERBATED RESPIRATORY DISEASE 38 0.0618
131 BACK INJURY 663 0.0609
132 USE OF ACCESSORY RESPIRATORY MUSCLES 25 0.0605
133 DEEP VEIN THROMBOSIS POSTOPERATIVE 120 0.0599
134 JOINT RANGE OF MOTION DECREASED 797 0.0594
135 OBESITY 924 0.0579
136 HAND DEFORMITY 746 0.0568
137 LIVE BIRTH 473 0.0565
138 SINUS OPERATION 134 0.0562
139 STATUS ASTHMATICUS 26 0.0551
140 SINUS POLYP 31 0.0537
141 RALES 311 0.0535
142 INCREASED VISCOSITY OF BRONCHIAL SECRETION 34 0.0533
143 INCREASED BRONCHIAL SECRETION 135 0.0527
144 PNEUMOCOCCAL INFECTION 31 0.0524
145 X-RAY ABNORMAL 93 0.0520
146 MONONEUROPATHY MULTIPLEX 24 0.0519
147 NASAL DISCHARGE DISCOLOURATION 71 0.0514
148 MULTIPLE ALLERGIES 400 0.0510
149 SYNOVITIS 919 0.0509
150 PERICARDITIS 853 0.0507
151 PRODUCT LABEL CONFUSION 295 0.0506
152 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 104 0.0501
153 PRODUCTIVE COUGH 2364 0.0495
154 NORMOCHROMIC NORMOCYTIC ANAEMIA 146 0.0486
155 EOSINOPHIL COUNT DECREASED 115 0.0483
156 SPUTUM INCREASED 103 0.0476
157 MYCOBACTERIAL INFECTION 82 0.0476
158 GRIP STRENGTH DECREASED 416 0.0472
159 HAEMOPHILUS INFECTION 46 0.0469
160 VASCULITIS 529 0.0454
161 DYSPNOEA PAROXYSMAL NOCTURNAL 33 0.0453
162 MUCOSAL DISCOLOURATION 29 0.0452
163 SUPERINFECTION 66 0.0440
164 EOSINOPHILIC MYOCARDITIS 32 0.0438
165 SWOLLEN JOINT COUNT INCREASED 139 0.0435
166 PRECANCEROUS CONDITION 29 0.0433
167 C-REACTIVE PROTEIN 40 0.0431
168 SARCOIDOSIS 201 0.0423
169 GLOSSODYNIA 941 0.0420
170 EOSINOPHILIA 730 0.0416
171 PORPHYRIA ACUTE 59 0.0411
172 IRRITABLE BOWEL SYNDROME 857 0.0399
173 VITAL FUNCTIONS ABNORMAL 34 0.0397
174 UPPER AIRWAY OBSTRUCTION 35 0.0395
175 KYPHOSIS 69 0.0390
176 SINUSITIS FUNGAL 31 0.0387
177 NOCTURNAL DYSPNOEA 49 0.0384
178 BLOOD LACTIC ACID INCREASED 201 0.0381
179 RHINITIS 304 0.0377
180 LOWER RESPIRATORY TRACT INFECTION 1712 0.0376
181 CARDIAC SEPTAL DEFECT 27 0.0376
182 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 25 0.0374
183 LUNG DISORDER 1803 0.0368
184 PLEURITIC PAIN 101 0.0366
185 TASTE DISORDER 734 0.0361
186 RHONCHI 49 0.0355
187 PULMONARY FUNCTION TEST DECREASED 155 0.0354
188 NASAL DISORDER 94 0.0353
189 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1645 0.0352
190 CONGENITAL ANOMALY 272 0.0351
191 PULMONARY ALVEOLAR HAEMORRHAGE 196 0.0349
192 WOUND 974 0.0348
193 BRONCHIAL DISORDER 54 0.0347
194 CREPITATIONS 103 0.0346
195 SOCIAL PROBLEM 142 0.0343
196 BONE EROSION 121 0.0342
197 STEROID DEPENDENCE 30 0.0342
198 NEUROLOGICAL SYMPTOM 189 0.0330
199 DYSPNOEA EXERTIONAL 1245 0.0330
200 PULMONARY MASS 490 0.0329
201 FIBROMYALGIA 796 0.0327
202 COELIAC DISEASE 321 0.0327
203 SECRETION DISCHARGE 406 0.0324
204 SENSE OF OPPRESSION 38 0.0323
205 JAUNDICE CHOLESTATIC 111 0.0314
206 CENTRAL OBESITY 23 0.0311
207 MICROANGIOPATHY 29 0.0309
208 SINUS PAIN 72 0.0308
209 NASAL OBSTRUCTION 57 0.0304
210 RESPIRATION ABNORMAL 208 0.0301
211 BLOOD TEST ABNORMAL 422 0.0300
212 BLOOD ALKALINE PHOSPHATASE ABNORMAL 27 0.0300
213 TYPE 2 DIABETES MELLITUS 993 0.0295
214 HYPOMANIA 105 0.0285
215 LIVER FUNCTION TEST INCREASED 600 0.0279
216 OXYGEN SATURATION ABNORMAL 77 0.0271
217 LIVER INJURY 665 0.0271
218 OBSTRUCTION 108 0.0270
219 POLYP 176 0.0269
220 ALLERGIC SINUSITIS 23 0.0268
221 IMPAIRED HEALING 876 0.0267
222 ARTERIOSCLEROSIS CORONARY ARTERY 176 0.0265
223 NIGHT SWEATS 847 0.0263
224 OBSTRUCTIVE SLEEP APNOEA SYNDROME 38 0.0260
225 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1355 0.0259
226 SYSTEMIC LUPUS ERYTHEMATOSUS 918 0.0258
227 RECTAL PROLAPSE 31 0.0257
228 PULMONARY FIBROSIS 490 0.0255
229 ADVERSE REACTION 337 0.0254
230 SNORING 96 0.0254
231 EPILEPSY 761 0.0249
232 CARDIAC MURMUR 215 0.0248
233 GAIT INABILITY 820 0.0245
234 ALLERGY TO ANIMAL 26 0.0244
235 EMPHYSEMA 246 0.0244
236 CAROTID ARTERIOSCLEROSIS 25 0.0242
237 CARBON DIOXIDE INCREASED 33 0.0242
238 EOSINOPHILIC PNEUMONIA 76 0.0241
239 CONTRAINDICATED PRODUCT ADMINISTERED 725 0.0239
240 ADJUSTMENT DISORDER 31 0.0238
241 C-REACTIVE PROTEIN INCREASED 868 0.0238
242 PNEUMONIA STREPTOCOCCAL 26 0.0237
243 NORMAL NEWBORN 128 0.0235
244 NASAL SEPTUM DEVIATION 46 0.0235
245 PRODUCT DOSE OMISSION ISSUE 6882 0.0234
246 RHEUMATOID FACTOR POSITIVE 135 0.0233
247 HYPERSENSITIVITY PNEUMONITIS 26 0.0228
248 MYCOBACTERIUM AVIUM COMPLEX INFECTION 60 0.0223
249 HYPERCAPNIA 67 0.0222
250 LUNG INFECTION 345 0.0222
251 BRONCHIOLITIS 78 0.0221
252 RESPIRATORY TRACT INFECTION 576 0.0221
253 FOETAL MALFORMATION 24 0.0221
254 OSTEOARTHRITIS 932 0.0220
255 POLYMYALGIA RHEUMATICA 69 0.0217
256 PULMONARY PAIN 63 0.0216
257 SINUS DISORDER 422 0.0213
258 PSORIATIC ARTHROPATHY 859 0.0211
259 NASAL CONGESTION 1240 0.0211
260 PULMONARY CONGESTION 278 0.0211
261 NEPHRECTOMY 31 0.0209
262 UPPER RESPIRATORY TRACT INFLAMMATION 25 0.0208
263 ATELECTASIS 201 0.0208
264 LOWER RESPIRATORY TRACT CONGESTION 35 0.0206
265 CORONAVIRUS INFECTION 136 0.0205
266 MIDDLE INSOMNIA 384 0.0205
267 SYMPTOM RECURRENCE 123 0.0205
268 TACHYARRHYTHMIA 51 0.0204
269 GASTROOESOPHAGEAL REFLUX DISEASE 1635 0.0203
270 SNEEZING 452 0.0201
271 GRANULOMATOSIS WITH POLYANGIITIS 24 0.0199
272 RESPIRATORY TRACT CONGESTION 315 0.0198
273 EXOSTOSIS 181 0.0198
274 CHEST DISCOMFORT 2013 0.0196
275 HAEMOPTYSIS 544 0.0195
276 EXPOSURE TO SARS-COV-2 33 0.0194
277 INFLAMMATION 995 0.0193
278 ASPIRATION 210 0.0192
279 DYSPNOEA 10802 0.0191
280 BRONCHOSPASM 272 0.0190
281 PHARYNGEAL ERYTHEMA 40 0.0189
282 FEMALE GENITAL TRACT FISTULA 32 0.0187
283 HYPERPHOSPHATAEMIA 40 0.0186
284 COUGH 5183 0.0185
285 THROAT CLEARING 69 0.0184
286 BLOOD CHOLESTEROL INCREASED 850 0.0182
287 VACCINATION FAILURE 30 0.0180
288 DEPRESSIVE SYMPTOM 63 0.0179
289 ACCIDENTAL EXPOSURE TO PRODUCT 1840 0.0178
290 RESPIRATORY DISORDER 529 0.0177
291 SINUS CONGESTION 237 0.0175
292 SEASONAL ALLERGY 248 0.0175
293 TERMINAL INSOMNIA 31 0.0175
294 ARTERIOSCLEROSIS 163 0.0173
295 ILL-DEFINED DISORDER 1049 0.0173
296 AUTOIMMUNE DISORDER 168 0.0172
297 THERAPEUTIC PRODUCT EFFECT DECREASED 762 0.0170
298 NASAL OEDEMA 30 0.0166
299 HYPOVENTILATION 54 0.0166
300 CUSHINGOID 53 0.0165
301 PARANASAL SINUS DISCOMFORT 61 0.0161
302 NODULE 210 0.0161
303 SLEEP DISORDER 1123 0.0159
304 INCREASED UPPER AIRWAY SECRETION 81 0.0158
305 PLATELET COUNT INCREASED 204 0.0156
306 ULCER HAEMORRHAGE 104 0.0154
307 BREAST CANCER STAGE II 127 0.0152
308 EMERGENCY CARE 46 0.0152
309 VIRAL UPPER RESPIRATORY TRACT INFECTION 72 0.0151
310 INFUSION RELATED REACTION 1002 0.0151
311 BLISTER 845 0.0150
312 RESPIRATORY TRACT INFECTION VIRAL 35 0.0150
313 PNEUMONIA 4750 0.0147
314 PATIENT DISSATISFACTION WITH TREATMENT 28 0.0145
315 BLOOD CALCIUM INCREASED 127 0.0145
316 DRUG TOLERANCE 73 0.0144
317 UPPER RESPIRATORY TRACT INFECTION 664 0.0144
318 SLEEP APNOEA SYNDROME 274 0.0143
319 ISCHAEMIC CARDIOMYOPATHY 44 0.0143
320 RHINORRHOEA 926 0.0143
321 MUSCULOSKELETAL PAIN 748 0.0143
322 EXERCISE TOLERANCE DECREASED 82 0.0142
323 HYPERAEMIA 28 0.0142
324 HYPERVENTILATION 82 0.0141
325 ASPHYXIA 115 0.0141
326 AORTIC STENOSIS 49 0.0141
327 ARTHROPATHY 780 0.0140
328 HOSPITALISATION 2131 0.0139
329 ALANINE AMINOTRANSFERASE ABNORMAL 29 0.0137
330 NECK PAIN 758 0.0135
331 EOSINOPHILIC OESOPHAGITIS 37 0.0133
332 NONSPECIFIC REACTION 73 0.0133
333 PAINFUL RESPIRATION 32 0.0133
334 HEPATIC ENZYME INCREASED 903 0.0132
335 PROCTITIS 37 0.0132
336 DRUG-INDUCED LIVER INJURY 409 0.0130
337 RADICULOPATHY 34 0.0129
338 LUNG CONSOLIDATION 36 0.0129
339 SKIN FRAGILITY 31 0.0127
340 HEPATITIS 325 0.0127
341 CHOKING SENSATION 70 0.0127
342 RED BLOOD CELL SEDIMENTATION RATE INCREASED 139 0.0125
343 ORTHOPNOEA 40 0.0125
344 HYPOXIA 442 0.0125
345 NASOPHARYNGITIS 2304 0.0125
346 DYSPNOEA AT REST 36 0.0124
347 IMPAIRED QUALITY OF LIFE 177 0.0123
348 SINUSITIS 1246 0.0121
349 DRY MOUTH 967 0.0119
350 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 202 0.0118
351 ENDOTRACHEAL INTUBATION 33 0.0118
352 MOBILITY DECREASED 845 0.0117
353 UPPER RESPIRATORY TRACT CONGESTION 34 0.0117
354 LUNG NEOPLASM 50 0.0117
355 SUFFOCATION FEELING 29 0.0117
356 CHOKING 228 0.0117
357 DECREASED ACTIVITY 126 0.0117
358 APHONIA 163 0.0117
359 MATERNAL EXPOSURE DURING PREGNANCY 1026 0.0115
360 WALKING AID USER 75 0.0114
361 ADRENAL INSUFFICIENCY 138 0.0114
362 BRONCHITIS 836 0.0113
363 SCIATICA 180 0.0113
364 GRANULOMA 39 0.0113
365 PNEUMONIA BACTERIAL 103 0.0112
366 SUSPECTED COVID-19 37 0.0112
367 DRUG INTOLERANCE 1081 0.0112
368 GENERAL PHYSICAL HEALTH DETERIORATION 1291 0.0111
369 ADENOCARCINOMA 25 0.0111
370 STOMATITIS 676 0.0111
371 ASPERGILLUS INFECTION 73 0.0111
372 PUSTULAR PSORIASIS 38 0.0111
373 INFLUENZA 1231 0.0110
374 HERNIA REPAIR 28 0.0108
375 LOWER LIMB FRACTURE 206 0.0107
376 DRUG TOLERANCE DECREASED 30 0.0107
377 BRONCHITIS CHRONIC 26 0.0106
378 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1917 0.0106
379 SWELLING 992 0.0106
380 EXPOSURE DURING PREGNANCY 657 0.0106
381 SCOLIOSIS 65 0.0105
382 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 68 0.0105
383 ORAL CANDIDIASIS 136 0.0103
384 ILLNESS 1051 0.0102
385 APPETITE DISORDER 67 0.0101
386 SARS-COV-2 TEST POSITIVE 133 0.0101
387 MIGRAINE 960 0.0100
388 BACTERIAL INFECTION 186 0.0100
389 BLOOD PRESSURE DIASTOLIC INCREASED 46 0.0100
390 CYSTIC FIBROSIS 55 0.0099
391 BUNDLE BRANCH BLOCK LEFT 42 0.0099
392 INJURY 696 0.0099
393 RIB FRACTURE 203 0.0099
394 UNDERDOSE 715 0.0098
395 OXYGEN SATURATION DECREASED 546 0.0097
396 QUALITY OF LIFE DECREASED 129 0.0096
397 VIRAL INFECTION 318 0.0095
398 DYSPHONIA 558 0.0095
399 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 48 0.0095
400 EYE PRURITUS 317 0.0094
401 EAR DISORDER 43 0.0094
402 HYPOTHYROIDISM 298 0.0093
403 CONDITION AGGRAVATED 2817 0.0093
404 LUPUS-LIKE SYNDROME 84 0.0093
405 PRODUCT STORAGE ISSUE 35 0.0092
406 RESPIRATORY RATE INCREASED 82 0.0092
407 SCHIZOPHRENIA 112 0.0092
408 OSTEOPOROSIS 379 0.0092
409 PSEUDOMONAS INFECTION 79 0.0092
410 EAR PAIN 178 0.0091
411 LACRIMATION INCREASED 275 0.0091
412 ANOSMIA 131 0.0090
413 SKIN ATROPHY 52 0.0090
414 VENTRICULAR HYPOKINESIA 29 0.0090
415 URTICARIA 1500 0.0089
416 JOINT SWELLING 1076 0.0089
417 DRUG EFFECT LESS THAN EXPECTED 132 0.0089
418 PRESCRIBED OVERDOSE 172 0.0089
419 STRIDOR 26 0.0088
420 DISCOMFORT 537 0.0088
421 BENIGN PROSTATIC HYPERPLASIA 45 0.0087
422 RHEUMATOID ARTHRITIS 987 0.0087
423 LUNG INFILTRATION 76 0.0086
424 PERIPHERAL SWELLING 1321 0.0086
425 EYE INJURY 26 0.0085
426 SKIN LACERATION 93 0.0085
427 FRUSTRATION TOLERANCE DECREASED 69 0.0085
428 PRESCRIBED UNDERDOSE 168 0.0084
429 TREATMENT FAILURE 695 0.0084
430 HYPOPNOEA 29 0.0083
431 DYSPEPSIA 817 0.0083
432 INTENTIONAL PRODUCT USE ISSUE 726 0.0083
433 RASH VESICULAR 40 0.0083
434 IRON DEFICIENCY 37 0.0082
435 PRODUCT DOSE OMISSION 536 0.0082
436 OROPHARYNGEAL PAIN 757 0.0082
437 HERPES ZOSTER 469 0.0082
438 GLAUCOMA 157 0.0081
439 TROPONIN INCREASED 62 0.0081
440 CATARACT OPERATION 48 0.0081
441 HYPOAESTHESIA 1198 0.0080
442 SPONDYLITIS 29 0.0080
443 PNEUMONITIS 215 0.0079
444 HYPERTENSION 1667 0.0079
445 OROPHARYNGEAL DISCOMFORT 71 0.0079
446 ARTHRITIS INFECTIVE 36 0.0078
447 SKIN LESION 212 0.0077
448 BLOOD POTASSIUM DECREASED 231 0.0077
449 MUSCULOSKELETAL STIFFNESS 673 0.0077
450 OCULAR DISCOMFORT 86 0.0077
451 EAR INFECTION 202 0.0076
452 INJECTION SITE REACTION 522 0.0076
453 PHARYNGITIS 94 0.0076
454 FLANK PAIN 71 0.0076
455 INCORRECT PRODUCT ADMINISTRATION DURATION 164 0.0076
456 GESTATIONAL DIABETES 36 0.0075
457 HIP ARTHROPLASTY 115 0.0075
458 UMBILICAL HERNIA 35 0.0075
459 KIDNEY INFECTION 145 0.0074
460 HEPATIC CYST 25 0.0074
461 PNEUMONIA FUNGAL 29 0.0073
462 HIATUS HERNIA 95 0.0073
463 NEAR DEATH EXPERIENCE 24 0.0073
464 GASTROINTESTINAL DISORDER 650 0.0072
465 MUSCULOSKELETAL CHEST PAIN 112 0.0072
466 RESPIRATORY SYNCYTIAL VIRUS INFECTION 63 0.0072
467 PNEUMOTHORAX 114 0.0072
468 CATARACT 428 0.0072
469 PRODUCT PREPARATION ISSUE 47 0.0072
470 PAROSMIA 54 0.0071
471 GASTRIC INFECTION 27 0.0071
472 LIMB INJURY 191 0.0070
473 HIP SURGERY 38 0.0070
474 OESOPHAGEAL DISORDER 27 0.0070
475 INFECTION 1011 0.0070
476 LUMBAR VERTEBRAL FRACTURE 32 0.0070
477 PRODUCT USE IN UNAPPROVED INDICATION 1729 0.0070
478 EYE OPERATION 32 0.0069
479 RHINOVIRUS INFECTION 27 0.0069
480 THERAPY CESSATION 356 0.0069
481 FOOD ALLERGY 53 0.0069
482 MEMORY IMPAIRMENT 933 0.0068
483 LUNG NEOPLASM MALIGNANT 278 0.0068
484 MUSCLE SPASMS 1240 0.0068
485 PARAESTHESIA 1056 0.0067
486 BRONCHOPULMONARY ASPERGILLOSIS 52 0.0067
487 ADVERSE DRUG REACTION 602 0.0067
488 CHOLELITHIASIS 218 0.0066
489 WHEELCHAIR USER 29 0.0065
490 MALAISE 2851 0.0065
491 LUNG TRANSPLANT 23 0.0065
492 CONFUSIONAL STATE 1046 0.0065
493 MUSCULAR WEAKNESS 729 0.0064
494 HYPERSENSITIVITY 1188 0.0064
495 MATERNAL EXPOSURE TIMING UNSPECIFIED 24 0.0064
496 DISEASE RECURRENCE 303 0.0064
497 RENAL CYST 50 0.0063
498 KNEE ARTHROPLASTY 132 0.0063
499 GLUCOSE TOLERANCE IMPAIRED 37 0.0063
500 GASTROENTERITIS 91 0.0062
501 ODYNOPHAGIA 37 0.0062
502 MYASTHENIA GRAVIS 50 0.0062
503 TOOTH ABSCESS 63 0.0062
504 OVERWEIGHT 33 0.0061
505 ANGINA PECTORIS 176 0.0061
506 CONTUSION 590 0.0061
507 COVID-19 PNEUMONIA 72 0.0061
508 CARDIAC PACEMAKER INSERTION 36 0.0060
509 THERAPEUTIC RESPONSE SHORTENED 200 0.0060
510 ABDOMINAL DISCOMFORT 1000 0.0060
511 CARDIOMYOPATHY 88 0.0059
512 IMMUNOSUPPRESSION 52 0.0059
513 ORAL INFECTION 23 0.0059
514 IMMUNE SYSTEM DISORDER 77 0.0058
515 PRODUCT ADMINISTRATION ERROR 118 0.0058
516 TRANSAMINASES INCREASED 129 0.0058
517 HEPATIC LESION 25 0.0058
518 BLOOD PRESSURE INCREASED 884 0.0058
519 ECZEMA 300 0.0057
520 DIABETES MELLITUS 437 0.0057
521 IMMOBILE 25 0.0057
522 NEURALGIA 139 0.0057
523 JOINT INJURY 122 0.0057
524 HYPERLIPIDAEMIA 68 0.0057
525 HYPOPHOSPHATAEMIA 42 0.0057
526 LEFT VENTRICULAR DYSFUNCTION 38 0.0057
527 DEVICE USE ERROR 196 0.0056
528 WEIGHT INCREASED 1259 0.0056
529 RESPIRATORY DISTRESS 155 0.0056
530 PARAESTHESIA ORAL 81 0.0056
531 MACULAR DEGENERATION 67 0.0056
532 HYPERTHYROIDISM 81 0.0056
533 HEPATIC CIRRHOSIS 105 0.0056
534 OEDEMA PERIPHERAL 681 0.0056
535 ABDOMINAL PAIN UPPER 1150 0.0056
536 JOINT DISLOCATION 59 0.0056
537 GOUT 100 0.0056
538 SUSPECTED OFF LABEL USE 25 0.0055
539 HEART RATE INCREASED 548 0.0055
540 BACK PAIN 1281 0.0055
541 DERMATITIS ALLERGIC 69 0.0055
542 TRANSIENT ISCHAEMIC ATTACK 184 0.0054
543 ABDOMINAL TENDERNESS 27 0.0054
544 LIMB OPERATION 26 0.0054
545 PAIN IN EXTREMITY 1594 0.0054
546 CONJUNCTIVITIS 100 0.0054
547 MYOSITIS 48 0.0053
548 PRODUCT QUALITY ISSUE 726 0.0053
549 SENSITIVITY TO WEATHER CHANGE 28 0.0053
550 ABDOMINAL DISTENSION 549 0.0053
551 ECCHYMOSIS 36 0.0052
552 CARDIAC OPERATION 45 0.0052
553 HEPATOTOXICITY 116 0.0052
554 STENT PLACEMENT 42 0.0052
555 SYNOVIAL CYST 24 0.0052
556 CONCUSSION 40 0.0052
557 SCRATCH 54 0.0051
558 LYMPHADENOPATHY 181 0.0051
559 CHEST PAIN 938 0.0051
560 TENDON DISORDER 33 0.0051
561 DEPRESSION 1150 0.0050
562 FOOT DEFORMITY 56 0.0050
563 ROAD TRAFFIC ACCIDENT 211 0.0050
564 ABDOMINAL HERNIA 23 0.0050
565 SPINAL OPERATION 62 0.0050
566 PHARYNGEAL SWELLING 49 0.0050
567 HEAD DISCOMFORT 88 0.0050
568 EAR DISCOMFORT 51 0.0050
569 PULMONARY OEDEMA 222 0.0050
570 ARTHRALGIA 2061 0.0050
571 BACK DISORDER 80 0.0049
572 FREQUENT BOWEL MOVEMENTS 132 0.0049
573 KNEE OPERATION 48 0.0049
574 ACCIDENT 58 0.0049
575 DISABILITY 96 0.0048
576 HYSTERECTOMY 42 0.0048
577 COVID-19 850 0.0048
578 INABILITY TO AFFORD MEDICATION 48 0.0048
579 CELLULITIS 242 0.0048
580 NASAL DISCOMFORT 38 0.0048
581 THERAPEUTIC RESPONSE UNEXPECTED 214 0.0048
582 JOINT STIFFNESS 124 0.0047
583 PAPULE 33 0.0047
584 CYSTITIS 149 0.0047
585 ARTHRITIS 368 0.0047
586 THYROID DISORDER 72 0.0047
587 ASTHENIA 1754 0.0047
588 PERIPHERAL VASCULAR DISORDER 24 0.0047
589 THROAT IRRITATION 209 0.0047
590 SCAB 53 0.0046
591 MICTURITION URGENCY 53 0.0046
592 CHOLECYSTECTOMY 53 0.0046
593 ANAPHYLACTIC REACTION 256 0.0046
594 FEAR OF INJECTION 33 0.0046
595 THROAT TIGHTNESS 124 0.0046
596 BODY TEMPERATURE DECREASED 45 0.0046
597 PYREXIA 1569 0.0045
598 PRODUCT DISTRIBUTION ISSUE 42 0.0045
599 PRODUCT USE ISSUE 844 0.0045
600 POST-TRAUMATIC STRESS DISORDER 30 0.0045
601 HEADACHE 2801 0.0045
602 DIVERTICULITIS 123 0.0044
603 ALOPECIA 871 0.0044
604 RASH 1928 0.0044
605 FALL 1472 0.0044
606 PULMONARY EMBOLISM 420 0.0044
607 GENERAL SYMPTOM 33 0.0044
608 PEMPHIGOID 33 0.0044
609 THROMBOSIS 350 0.0043
610 ATRIAL FIBRILLATION 422 0.0043
611 IMMUNODEFICIENCY 64 0.0043
612 PAIN 2633 0.0043
613 BEDRIDDEN 56 0.0043
614 BLOOD PRESSURE SYSTOLIC INCREASED 83 0.0043
615 RENAL PAIN 45 0.0042
616 APNOEA 33 0.0042
617 INSOMNIA 1119 0.0042
618 FEEDING DISORDER 84 0.0041
619 SURGERY 241 0.0041
620 BLOOD BILIRUBIN INCREASED 111 0.0041
621 FATIGUE 3188 0.0041
622 ORAL DISORDER 30 0.0041
623 DRUG EFFECT INCOMPLETE 147 0.0040
624 LIGAMENT SPRAIN 40 0.0040
625 PRODUCT AVAILABILITY ISSUE 92 0.0040
626 NERVE COMPRESSION 37 0.0040
627 POOR QUALITY SLEEP 86 0.0040
628 INJECTION SITE DISCOMFORT 42 0.0040
629 ACUTE CORONARY SYNDROME 33 0.0040
630 THERAPY NON-RESPONDER 179 0.0040
631 BLOOD PRESSURE ABNORMAL 79 0.0040
632 MUSCULOSKELETAL DISCOMFORT 68 0.0039
633 TREATMENT NONCOMPLIANCE 216 0.0039
634 PULMONARY THROMBOSIS 43 0.0039
635 FUNGAL INFECTION 131 0.0039
636 PSYCHOTIC DISORDER 116 0.0039
637 LEUKAEMIA 37 0.0039
638 LIVER DISORDER 173 0.0039
639 THERAPEUTIC RESPONSE DECREASED 236 0.0039
640 BLOOD IRON DECREASED 46 0.0039
641 BLOOD DISORDER 31 0.0039
642 EYE DISORDER 127 0.0039
643 NEPHROLITHIASIS 176 0.0038
644 INCORRECT DOSE ADMINISTERED 875 0.0038
645 TACHYCARDIA 338 0.0038
646 JOINT EFFUSION 26 0.0038
647 ESCHERICHIA INFECTION 31 0.0038
648 FACIAL PARALYSIS 32 0.0038
649 PURPURA 33 0.0037
650 FEELING HOT 228 0.0037
651 DIZZINESS 1848 0.0037
652 DRUG INEFFECTIVE 4798 0.0036
653 WEIGHT FLUCTUATION 38 0.0036
654 THERAPY INTERRUPTED 259 0.0036
655 LOCALISED INFECTION 87 0.0036
656 OFF LABEL USE 3150 0.0036
657 SKIN MASS 24 0.0036
658 BREAST MASS 24 0.0036
659 HEART RATE DECREASED 125 0.0036
660 VAGINAL DISCHARGE 36 0.0036
661 DELIRIUM 123 0.0035
662 OEDEMA 191 0.0035
663 WHITE BLOOD CELL COUNT INCREASED 135 0.0035
664 RECTAL HAEMORRHAGE 151 0.0035
665 INFLUENZA LIKE ILLNESS 289 0.0035
666 SKIN DISORDER 117 0.0035
667 MYALGIA 594 0.0035
668 CARDIAC DISORDER 326 0.0035
669 ULCER 55 0.0035
670 EYE INFECTION 39 0.0035
671 SPINAL FRACTURE 69 0.0034
672 HEART RATE IRREGULAR 77 0.0034
673 GAIT DISTURBANCE 652 0.0034
674 ANXIETY 963 0.0034
675 ACUTE RESPIRATORY FAILURE 65 0.0034
676 CANDIDA INFECTION 57 0.0034
677 INFARCTION 23 0.0034
678 PRODUCT STORAGE ERROR 294 0.0034
679 APPENDICITIS 31 0.0033
680 ADVERSE EVENT 303 0.0033
681 DEPRESSED MOOD 173 0.0033
682 FACIAL PAIN 29 0.0032
683 RASH PRURITIC 176 0.0032
684 TACHYPNOEA 44 0.0032
685 FOOT FRACTURE 61 0.0032
686 SKIN INFECTION 36 0.0032
687 BLOOD GLUCOSE FLUCTUATION 35 0.0032
688 REBOUND EFFECT 36 0.0032
689 AMNESIA 207 0.0032
690 UPPER LIMB FRACTURE 63 0.0032
691 CARDIAC FAILURE CONGESTIVE 254 0.0032
692 HERNIA 61 0.0032
693 DRY THROAT 32 0.0031
694 CYST 39 0.0031
695 ABDOMINAL PAIN 728 0.0031
696 PSYCHIATRIC SYMPTOM 23 0.0031
697 HEPATIC STEATOSIS 58 0.0031
698 RESPIRATORY FAILURE 227 0.0031
699 HYPOACUSIS 134 0.0031
700 LIMB DISCOMFORT 96 0.0031
701 WEIGHT DECREASED 860 0.0031
702 INJECTION SITE PAIN 944 0.0031
703 NERVE INJURY 34 0.0031
704 DECREASED APPETITE 706 0.0030
705 EYE SWELLING 112 0.0030
706 PANCREATITIS 159 0.0030
707 MUSCLE STRAIN 26 0.0030
708 SENSORY DISTURBANCE 48 0.0030
709 HIP FRACTURE 96 0.0030
710 LYMPHOMA 46 0.0030
711 HAEMORRHOIDS 58 0.0030
712 FOETAL EXPOSURE DURING PREGNANCY 241 0.0030
713 PNEUMONIA ASPIRATION 74 0.0030
714 OCULAR HYPERAEMIA 140 0.0029
715 RASH ERYTHEMATOUS 141 0.0029
716 CARDIOMEGALY 36 0.0029
717 VOMITING 1375 0.0029
718 PLEURAL EFFUSION 177 0.0029
719 PYELONEPHRITIS 25 0.0029
720 BRAIN FOG 45 0.0029
721 POST PROCEDURAL COMPLICATION 55 0.0029
722 DECREASED IMMUNE RESPONSIVENESS 28 0.0029
723 INJECTION SITE URTICARIA 70 0.0029
724 URINARY RETENTION 95 0.0028
725 CORONARY ARTERY DISEASE 86 0.0028
726 BRAIN NEOPLASM 26 0.0028
727 BLOOD PRESSURE DECREASED 188 0.0028
728 COLITIS ULCERATIVE 126 0.0028
729 BODY TEMPERATURE INCREASED 57 0.0028
730 INTERVERTEBRAL DISC PROTRUSION 61 0.0028
731 CHILLS 324 0.0028
732 INSURANCE ISSUE 42 0.0027
733 BLOOD URINE PRESENT 52 0.0027
734 GROIN PAIN 24 0.0027
735 SWOLLEN TONGUE 85 0.0027
736 PRODUCT DOSE OMISSION IN ERROR 77 0.0027
737 BURNING SENSATION 190 0.0027
738 PRODUCT PRESCRIBING ISSUE 59 0.0027
739 PRODUCT PREPARATION ERROR 55 0.0027
740 BLOOD PRESSURE FLUCTUATION 64 0.0027
741 TOOTH INFECTION 35 0.0027
742 ACUTE MYOCARDIAL INFARCTION 78 0.0026
743 SWELLING FACE 172 0.0026
744 VERTIGO 160 0.0026
745 BLADDER DISORDER 26 0.0026
746 SPEECH DISORDER 136 0.0026
747 NEOPLASM MALIGNANT 173 0.0026
748 SKIN CANCER 55 0.0026
749 GASTROENTERITIS VIRAL 46 0.0025
750 HAEMATOMA 66 0.0025
751 COLITIS 96 0.0025
752 URINARY INCONTINENCE 75 0.0025
753 HOSPICE CARE 25 0.0025
754 MYOCARDITIS 29 0.0025
755 DEAFNESS 66 0.0025
756 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 85 0.0025
757 PALPITATIONS 294 0.0025
758 INJECTION SITE RASH 77 0.0025
759 SYNCOPE 251 0.0025
760 LABORATORY TEST ABNORMAL 74 0.0025
761 WRIST FRACTURE 30 0.0025
762 TOOTH EXTRACTION 31 0.0025
763 INTENTIONAL DOSE OMISSION 71 0.0025
764 TREMOR 413 0.0025
765 AGEUSIA 62 0.0025
766 PRURITUS 955 0.0025
767 COLON CANCER 37 0.0025
768 OESOPHAGITIS 27 0.0025
769 VITAMIN D DEFICIENCY 24 0.0025
770 ARRHYTHMIA 116 0.0024
771 FLUID RETENTION 124 0.0024
772 BASAL CELL CARCINOMA 38 0.0024
773 HEAD INJURY 77 0.0024
774 ORAL HERPES 47 0.0024
775 URINARY TRACT INFECTION 408 0.0024
776 ANKLE FRACTURE 37 0.0024
777 DERMATITIS 50 0.0024
778 COLD SWEAT 42 0.0024
779 ACCIDENTAL UNDERDOSE 34 0.0024
780 PRODUCT DISPENSING ERROR 51 0.0023
781 VISUAL IMPAIRMENT 290 0.0023
782 BLINDNESS UNILATERAL 33 0.0023
783 INJECTION SITE SWELLING 177 0.0023
784 OSTEOPENIA 35 0.0023
785 SPINAL PAIN 27 0.0023
786 THYROID CANCER 27 0.0022
787 PHOTOPHOBIA 42 0.0022
788 HYPERSOMNIA 64 0.0022
789 NEUROPATHY PERIPHERAL 212 0.0022
790 PRURITUS GENERALISED 48 0.0022
791 DEMENTIA 62 0.0022
792 PHARYNGITIS STREPTOCOCCAL 24 0.0022
793 INCORRECT DOSE ADMINISTERED BY DEVICE 58 0.0022
794 ANAPHYLACTIC SHOCK 57 0.0022
795 RETCHING 47 0.0022
796 PROCEDURAL PAIN 61 0.0022
797 END STAGE RENAL DISEASE 40 0.0022
798 BLOOD CREATININE INCREASED 143 0.0022
799 MOVEMENT DISORDER 70 0.0022
800 DIARRHOEA 1404 0.0022
801 DEATH 1870 0.0022
802 DYSPHAGIA 205 0.0022
803 BONE PAIN 126 0.0021
804 MASS 30 0.0021
805 INJECTION SITE PRURITUS 143 0.0021
806 LOSS OF CONSCIOUSNESS 273 0.0021
807 ERYTHEMA 436 0.0021
808 SINUS TACHYCARDIA 30 0.0021
809 DERMATITIS CONTACT 24 0.0021
810 NAUSEA 1661 0.0021
811 STAPHYLOCOCCAL INFECTION 69 0.0021
812 MALIGNANT MELANOMA 28 0.0021
813 RENAL DISORDER 97 0.0021
814 INJECTION SITE BRUISING 164 0.0021
815 DYSSTASIA 60 0.0021
816 TOOTHACHE 37 0.0020
817 CYANOSIS 32 0.0020
818 METASTASES TO CENTRAL NERVOUS SYSTEM 26 0.0020
819 MULTIPLE ORGAN DYSFUNCTION SYNDROME 57 0.0020
820 FEELING ABNORMAL 477 0.0020
821 DYSURIA 73 0.0020
822 LYMPHOPENIA 28 0.0020
823 NOCTURIA 24 0.0020
824 SMALL INTESTINAL OBSTRUCTION 24 0.0019
825 MYOCARDIAL INFARCTION 339 0.0019
826 FEELING COLD 54 0.0019
827 SKIN DISCOLOURATION 89 0.0019
828 DIPLOPIA 50 0.0019
829 HAEMATOCHEZIA 106 0.0019
830 CEREBROVASCULAR ACCIDENT 325 0.0019
831 RASH MACULAR 67 0.0019
832 PALLOR 52 0.0019
833 SEPSIS 211 0.0019
834 MUSCULOSKELETAL DISORDER 36 0.0019
835 EYE HAEMORRHAGE 25 0.0019
836 INJECTION SITE HAEMORRHAGE 149 0.0019
837 DIABETES MELLITUS INADEQUATE CONTROL 33 0.0019
838 PERICARDIAL EFFUSION 43 0.0019
839 INTERSTITIAL LUNG DISEASE 90 0.0019
840 NERVOUSNESS 97 0.0019
841 CARDIOVASCULAR DISORDER 47 0.0018
842 PREGNANCY 37 0.0018
843 FACE OEDEMA 31 0.0018
844 DERMATITIS ATOPIC 96 0.0018
845 SCAR 31 0.0018
846 PRODUCT PRESCRIBING ERROR 43 0.0018
847 ANAEMIA 343 0.0018
848 INJECTION SITE HAEMATOMA 26 0.0018
849 VISION BLURRED 243 0.0018
850 HAEMORRHAGE 183 0.0017
851 FRACTURE 33 0.0017
852 CARDIAC FAILURE 139 0.0017
853 LIP SWELLING 57 0.0017
854 SKIN REACTION 24 0.0017
855 OSTEOMYELITIS 30 0.0017
856 RENAL IMPAIRMENT 139 0.0017
857 HYPERGLYCAEMIA 60 0.0016
858 EPISTAXIS 123 0.0016
859 MEDICATION ERROR 90 0.0016
860 DEVICE USE ISSUE 28 0.0016
861 INJECTION SITE ERYTHEMA 198 0.0016
862 EMOTIONAL DISTRESS 193 0.0016
863 SOMNOLENCE 320 0.0016
864 RASH GENERALISED 41 0.0016
865 MOUTH ULCERATION 33 0.0016
866 HYPOTENSION 314 0.0016
867 HYPERHIDROSIS 200 0.0016
868 MUSCLE TIGHTNESS 25 0.0015
869 RESTLESS LEGS SYNDROME 28 0.0015
870 BALANCE DISORDER 132 0.0015
871 HYPOAESTHESIA ORAL 23 0.0015
872 SKIN EXFOLIATION 128 0.0015
873 RASH PAPULAR 34 0.0015
874 GALLBLADDER DISORDER 27 0.0015
875 INTESTINAL OBSTRUCTION 57 0.0015
876 CLOSTRIDIUM DIFFICILE INFECTION 33 0.0015
877 POLLAKIURIA 63 0.0015
878 DEEP VEIN THROMBOSIS 97 0.0015
879 CONSTIPATION 325 0.0015
880 DRUG DOSE OMISSION 245 0.0015
881 FLATULENCE 84 0.0015
882 EXTRA DOSE ADMINISTERED 60 0.0015
883 RED BLOOD CELL COUNT DECREASED 42 0.0015
884 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 43 0.0015
885 ISCHAEMIC STROKE 26 0.0015
886 AGGRESSION 72 0.0014
887 FAECES DISCOLOURED 31 0.0014
888 GASTRIC ULCER 27 0.0014
889 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 26 0.0014
890 DYSARTHRIA 53 0.0014
891 HYPONATRAEMIA 78 0.0014
892 ABDOMINAL PAIN LOWER 35 0.0014
893 ANGIOEDEMA 61 0.0014
894 HAEMATURIA 47 0.0014
895 BONE DISORDER 25 0.0014
896 DRUG DEPENDENCE 218 0.0014
897 MENTAL DISORDER 59 0.0014
898 PROSTATE CANCER 109 0.0014
899 OVERDOSE 291 0.0013
900 ASCITES 39 0.0013
901 APHASIA 40 0.0013
902 FEMUR FRACTURE 41 0.0013
903 EATING DISORDER 28 0.0013
904 INJECTION SITE WARMTH 27 0.0013
905 FEAR 35 0.0013
906 DRUG EFFECT DECREASED 70 0.0013
907 BLOOD GLUCOSE ABNORMAL 24 0.0013
908 SEIZURE 149 0.0013
909 DRY SKIN 172 0.0013
910 GASTRIC DISORDER 44 0.0013
911 OSTEONECROSIS 41 0.0012
912 ABORTION SPONTANEOUS 50 0.0012
913 DRY EYE 62 0.0012
914 PANIC ATTACK 45 0.0012
915 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 66 0.0012
916 COGNITIVE DISORDER 56 0.0012
917 HOT FLUSH 89 0.0012
918 BREAST CANCER 109 0.0012
919 IMPAIRED WORK ABILITY 25 0.0012
920 BLINDNESS 47 0.0012
921 CARDIAC ARREST 95 0.0011
922 MOOD SWINGS 36 0.0011
923 SEPTIC SHOCK 49 0.0011
924 PANCREATIC CARCINOMA 32 0.0011
925 HALLUCINATION 83 0.0011
926 RESPIRATORY ARREST 30 0.0011
927 INTENTIONAL PRODUCT MISUSE 94 0.0011
928 FLUSHING 109 0.0011
929 HAEMATEMESIS 27 0.0011
930 CEREBRAL INFARCTION 26 0.0011
931 MUSCLE TWITCHING 24 0.0010
932 HYPOKALAEMIA 48 0.0010
933 RENAL FAILURE 138 0.0010
934 NERVOUS SYSTEM DISORDER 32 0.0010
935 HYPOPHAGIA 26 0.0010
936 EYE PAIN 57 0.0010
937 LETHARGY 58 0.0010
938 SKIN ULCER 26 0.0010
939 DEHYDRATION 134 0.0010
940 PSORIASIS 131 0.0010
941 HAEMOGLOBIN DECREASED 101 0.0010
942 EMOTIONAL DISORDER 30 0.0010
943 GLYCOSYLATED HAEMOGLOBIN INCREASED 24 0.0009
944 GASTRITIS 25 0.0009
945 INJECTION SITE MASS 35 0.0009
946 PRESYNCOPE 23 0.0009
947 BREAST CANCER FEMALE 25 0.0009
948 CRYING 34 0.0009
949 IRRITABILITY 56 0.0009
950 COMA 44 0.0009
951 MULTIPLE SCLEROSIS 44 0.0009
952 TINNITUS 42 0.0009
953 NEEDLE ISSUE 26 0.0009
954 PAIN IN JAW 25 0.0009
955 NO ADVERSE EVENT 159 0.0009
956 SUICIDAL IDEATION 80 0.0009
957 AGITATION 64 0.0009
958 EYE IRRITATION 50 0.0009
959 DYSGEUSIA 64 0.0009
960 ACCIDENTAL OVERDOSE 30 0.0008
961 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 58 0.0008
962 DISORIENTATION 32 0.0008
963 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 163 0.0008
964 CHRONIC KIDNEY DISEASE 58 0.0008
965 UNEVALUABLE EVENT 54 0.0007
966 NEUTROPHIL COUNT DECREASED 29 0.0007
967 DEVICE LEAKAGE 30 0.0007
968 BLOOD GLUCOSE DECREASED 33 0.0007
969 DISTURBANCE IN ATTENTION 36 0.0007
970 SKIN BURNING SENSATION 47 0.0007
971 DEVICE MALFUNCTION 46 0.0007
972 BLOOD GLUCOSE INCREASED 122 0.0006
973 DISEASE PROGRESSION 74 0.0006
974 BRADYCARDIA 32 0.0006
975 SKIN IRRITATION 24 0.0005
976 LEUKOPENIA 25 0.0005
977 GASTROINTESTINAL HAEMORRHAGE 41 0.0005
978 ACNE 36 0.0005
979 HYPOGLYCAEMIA 23 0.0005
980 DEVICE ISSUE 36 0.0004
981 WHITE BLOOD CELL COUNT DECREASED 41 0.0004
982 ACUTE KIDNEY INJURY 49 0.0003
983 THROMBOCYTOPENIA 35 0.0003
984 DRUG ABUSE 26 0.0003
985 DRUG DOSE OMISSION BY DEVICE 24 0.0003
986 PLATELET COUNT DECREASED 24 0.0002
987 DRUG INTERACTION 34 0.0002
988 NEUTROPENIA 27 0.0002
989 TOXICITY TO VARIOUS AGENTS 25 0.0001